0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Blood Product Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: September 2022
|
Report Code: QYRE-Auto-1089
Home | Market Reports | Health| Nursing
Global Blood Product Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Blood Product Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-1089
Report
September 2022
132 Pages
QYResearch
Region: Global, North America, Europe, Asia
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Blood Product market is projected to reach US$ 47570 million by 2028 from an estimated US$ 30660 million in 2022, at a CAGR of 7.6% during 2023 and 2028.

The major players in global blood product market include Takeda, CSL, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Blood Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Blood Product.
The Blood Product market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Blood Product market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Product companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
Shanghai RAAS
China Biologic Products
Hualan Biological Engineering Inc.
Beijing Tiantan Biological Products Corp
Pacific Shuanglin
Boya Bio-Pharmaceutical
Paisi Feike Biology Pharmacy Co., Ltd.
Xinjiang Deyuan Bioengineering
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Shenzhen Weiguang
Shanxi Kangbao
Nanyue Biopharming Corporation Ltd
Product Type Insights
Global markets are presented by Blood Product type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Blood Product are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Blood Product Segment by Type

Albumin
Immunoglobulin
Clotting Factor
Others
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Blood Product market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Blood Product market.

Blood Product Segment by Application

Bleeding Wound
Immunodeficiency
HBV
Tetanus
Rabies
Hemophilia
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Blood Product market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Blood Product and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Blood Product industry.
This report helps stakeholders to gain insights into which regions to target globally.
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Product.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

1 Study Coverage
1.1 Blood Product Product Introduction
1.2 Market by Type
1.2.1 Global Blood Product Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Albumin
1.2.3 Immunoglobulin
1.2.4 Clotting Factor
1.2.5 Others
1.3 Market by Application
1.3.1 Global Blood Product Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Bleeding Wound
1.3.3 Immunodeficiency
1.3.4 HBV
1.3.5 Tetanus
1.3.6 Rabies
1.3.7 Hemophilia
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Blood Product Market Size Estimates and Forecasts
2.2 Blood Product Market Size by Region: 2022 Versus 2028
2.2.1 Global Blood Product Revenue by Region: 2017-2022
2.2.2 Global Blood Product Revenue Forecast by Region (2023-2028)
2.2.3 Global Blood Product Revenue Market Share by Region (2017-2028)
3 Global Blood Product by Company
3.1 Global Blood Product Revenue by Company (2017-2022)
3.2 Global Blood Product Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Blood Product Companies around the World: Ranking by Revenue
3.3.2 Global Blood Product Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Blood Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Blood Product Companies Headquarters & Product Type
3.4.1 Blood Product Companies Headquarters
3.4.2 Global Blood Product Companies Product & Service
3.4.3 Date of International Companies Enter into Blood Product Market
3.5 Global Blood Product Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Takeda
4.1.1 Takeda Corporation Information
4.1.2 Takeda Description, Business Overview
4.1.3 Takeda Blood Product Products Offered
4.1.4 Takeda Blood Product Revenue and Gross Margin (2017-2022)
4.1.5 Takeda Blood Product Revenue by Product in 2021
4.1.6 Takeda Blood Product Revenue by Application in 2021
4.1.7 Takeda Blood Product Revenue by Geographic Area in 2021
4.1.8 Takeda Recent Developments
4.2 CSL
4.2.1 CSL Corporation Information
4.2.2 CSL Description, Business Overview
4.2.3 CSL Blood Product Products Offered
4.2.4 CSL Blood Product Revenue and Gross Margin (2017-2022)
4.2.5 CSL Blood Product Revenue by Product in 2021
4.2.6 CSL Blood Product Revenue by Application in 2021
4.2.7 CSL Blood Product Revenue by Geographic Area in 2021
4.2.8 CSL Recent Developments
4.3 Grifols
4.3.1 Grifols Corporation Information
4.3.2 Grifols Description, Business Overview
4.3.3 Grifols Blood Product Products Offered
4.3.4 Grifols Blood Product Revenue and Gross Margin (2017-2022)
4.3.5 Grifols Blood Product Revenue by Product in 2021
4.3.6 Grifols Blood Product Revenue by Application in 2021
4.3.7 Grifols Blood Product Revenue by Geographic Area in 2021
4.3.8 Grifols Recent Developments
4.4 Octapharma
4.4.1 Octapharma Corporation Information
4.4.2 Octapharma Description, Business Overview
4.4.3 Octapharma Blood Product Products Offered
4.4.4 Octapharma Blood Product Revenue and Gross Margin (2017-2022)
4.4.5 Octapharma Blood Product Revenue by Product in 2021
4.4.6 Octapharma Blood Product Revenue by Application in 2021
4.4.7 Octapharma Blood Product Revenue by Geographic Area in 2021
4.4.8 Octapharma Recent Developments
4.5 Kedrion
4.5.1 Kedrion Corporation Information
4.5.2 Kedrion Description, Business Overview
4.5.3 Kedrion Blood Product Products Offered
4.5.4 Kedrion Blood Product Revenue and Gross Margin (2017-2022)
4.5.5 Kedrion Blood Product Revenue by Product in 2021
4.5.6 Kedrion Blood Product Revenue by Application in 2021
4.5.7 Kedrion Blood Product Revenue by Geographic Area in 2021
4.5.8 Kedrion Recent Developments
4.6 LFB Group
4.6.1 LFB Group Corporation Information
4.6.2 LFB Group Description, Business Overview
4.6.3 LFB Group Blood Product Products Offered
4.6.4 LFB Group Blood Product Revenue and Gross Margin (2017-2022)
4.6.5 LFB Group Blood Product Revenue by Product in 2021
4.6.6 LFB Group Blood Product Revenue by Application in 2021
4.6.7 LFB Group Blood Product Revenue by Geographic Area in 2021
4.6.8 LFB Group Recent Development
4.7 Biotest
4.7.1 Biotest Corporation Information
4.7.2 Biotest Description, Business Overview
4.7.3 Biotest Blood Product Products Offered
4.7.4 Biotest Blood Product Revenue and Gross Margin (2017-2022)
4.7.5 Biotest Blood Product Revenue by Product in 2021
4.7.6 Biotest Blood Product Revenue by Application in 2021
4.7.7 Biotest Blood Product Revenue by Geographic Area in 2021
4.7.8 Biotest Recent Development
4.8 BPL
4.8.1 BPL Corporation Information
4.8.2 BPL Description, Business Overview
4.8.3 BPL Blood Product Products Offered
4.8.4 BPL Blood Product Revenue and Gross Margin (2017-2022)
4.8.5 BPL Blood Product Revenue by Product in 2021
4.8.6 BPL Blood Product Revenue by Application in 2021
4.8.7 BPL Blood Product Revenue by Geographic Area in 2021
4.8.8 BPL Recent Development
4.9 Shanghai RAAS
4.9.1 Shanghai RAAS Corporation Information
4.9.2 Shanghai RAAS Description, Business Overview
4.9.3 Shanghai RAAS Blood Product Products Offered
4.9.4 Shanghai RAAS Blood Product Revenue and Gross Margin (2017-2022)
4.9.5 Shanghai RAAS Blood Product Revenue by Product in 2021
4.9.6 Shanghai RAAS Blood Product Revenue by Application in 2021
4.9.7 Shanghai RAAS Blood Product Revenue by Geographic Area in 2021
4.9.8 Shanghai RAAS Recent Development
4.10 China Biologic Products
4.10.1 China Biologic Products Corporation Information
4.10.2 China Biologic Products Description, Business Overview
4.10.3 China Biologic Products Blood Product Products Offered
4.10.4 China Biologic Products Blood Product Revenue and Gross Margin (2017-2022)
4.10.5 China Biologic Products Blood Product Revenue by Product in 2021
4.10.6 China Biologic Products Blood Product Revenue by Application in 2021
4.10.7 China Biologic Products Blood Product Revenue by Geographic Area in 2021
4.10.8 China Biologic Products Recent Development
4.11 Hualan Biological Engineering Inc.
4.11.1 Hualan Biological Engineering Inc. Corporation Information
4.11.2 Hualan Biological Engineering Inc. Description, Business Overview
4.11.3 Hualan Biological Engineering Inc. Blood Product Products Offered
4.11.4 Hualan Biological Engineering Inc. Blood Product Revenue and Gross Margin (2017-2022)
4.11.5 Hualan Biological Engineering Inc. Blood Product Revenue by Product in 2021
4.11.6 Hualan Biological Engineering Inc. Blood Product Revenue by Application in 2021
4.11.7 Hualan Biological Engineering Inc. Blood Product Revenue by Geographic Area in 2021
4.11.8 Hualan Biological Engineering Inc. Recent Development
4.12 Beijing Tiantan Biological Products Corp
4.12.1 Beijing Tiantan Biological Products Corp Corporation Information
4.12.2 Beijing Tiantan Biological Products Corp Description, Business Overview
4.12.3 Beijing Tiantan Biological Products Corp Blood Product Products Offered
4.12.4 Beijing Tiantan Biological Products Corp Blood Product Revenue and Gross Margin (2017-2022)
4.12.5 Beijing Tiantan Biological Products Corp Blood Product Revenue by Product in 2021
4.12.6 Beijing Tiantan Biological Products Corp Blood Product Revenue by Application in 2021
4.12.7 Beijing Tiantan Biological Products Corp Blood Product Revenue by Geographic Area in 2021
4.12.8 Beijing Tiantan Biological Products Corp Recent Development
4.13 Pacific Shuanglin
4.13.1 Pacific Shuanglin Corporation Information
4.13.2 Pacific Shuanglin Description, Business Overview
4.13.3 Pacific Shuanglin Blood Product Products Offered
4.13.4 Pacific Shuanglin Blood Product Revenue and Gross Margin (2017-2022)
4.13.5 Pacific Shuanglin Blood Product Revenue by Product in 2021
4.13.6 Pacific Shuanglin Blood Product Revenue by Application in 2021
4.13.7 Pacific Shuanglin Blood Product Revenue by Geographic Area in 2021
4.13.8 Pacific Shuanglin Recent Development
4.14 Boya Bio-Pharmaceutical
4.14.1 Boya Bio-Pharmaceutical Corporation Information
4.14.2 Boya Bio-Pharmaceutical Description, Business Overview
4.14.3 Boya Bio-Pharmaceutical Blood Product Products Offered
4.14.4 Boya Bio-Pharmaceutical Blood Product Revenue and Gross Margin (2017-2022)
4.14.5 Boya Bio-Pharmaceutical Blood Product Revenue by Product in 2021
4.14.6 Boya Bio-Pharmaceutical Blood Product Revenue by Application in 2021
4.14.7 Boya Bio-Pharmaceutical Blood Product Revenue by Geographic Area in 2021
4.14.8 Boya Bio-Pharmaceutical Recent Development
4.15 Paisi Feike Biology Pharmacy Co., Ltd.
4.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Corporation Information
4.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Description, Business Overview
4.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Products Offered
4.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue and Gross Margin (2017-2022)
4.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue by Product in 2021
4.15.6 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue by Application in 2021
4.15.7 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue by Geographic Area in 2021
4.15.8 Paisi Feike Biology Pharmacy Co., Ltd. Recent Development
4.16 Xinjiang Deyuan Bioengineering
4.16.1 Xinjiang Deyuan Bioengineering Corporation Information
4.16.2 Xinjiang Deyuan Bioengineering Description, Business Overview
4.16.3 Xinjiang Deyuan Bioengineering Blood Product Products Offered
4.16.4 Xinjiang Deyuan Bioengineering Blood Product Revenue and Gross Margin (2017-2022)
4.16.5 Xinjiang Deyuan Bioengineering Blood Product Revenue by Product in 2021
4.16.6 Xinjiang Deyuan Bioengineering Blood Product Revenue by Application in 2021
4.16.7 Xinjiang Deyuan Bioengineering Blood Product Revenue by Geographic Area in 2021
4.16.8 Xinjiang Deyuan Bioengineering Recent Development
4.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
4.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Corporation Information
4.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Description, Business Overview
4.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Products Offered
4.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue and Gross Margin (2017-2022)
4.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue by Product in 2021
4.17.6 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue by Application in 2021
4.17.7 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue by Geographic Area in 2021
4.17.8 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Development
4.18 Shenzhen Weiguang
4.18.1 Shenzhen Weiguang Corporation Information
4.18.2 Shenzhen Weiguang Description, Business Overview
4.18.3 Shenzhen Weiguang Blood Product Products Offered
4.18.4 Shenzhen Weiguang Blood Product Revenue and Gross Margin (2017-2022)
4.18.5 Shenzhen Weiguang Blood Product Revenue by Product in 2021
4.18.6 Shenzhen Weiguang Blood Product Revenue by Application in 2021
4.18.7 Shenzhen Weiguang Blood Product Revenue by Geographic Area in 2021
4.18.8 Shenzhen Weiguang Recent Development
4.19 Shanxi Kangbao
4.19.1 Shanxi Kangbao Corporation Information
4.19.2 Shanxi Kangbao Description, Business Overview
4.19.3 Shanxi Kangbao Blood Product Products Offered
4.19.4 Shanxi Kangbao Blood Product Revenue and Gross Margin (2017-2022)
4.19.5 Shanxi Kangbao Blood Product Revenue by Product in 2021
4.19.6 Shanxi Kangbao Blood Product Revenue by Application in 2021
4.19.7 Shanxi Kangbao Blood Product Revenue by Geographic Area in 2021
4.19.8 Shanxi Kangbao Recent Development
4.20 Nanyue Biopharming Corporation Ltd
4.20.1 Nanyue Biopharming Corporation Ltd Corporation Information
4.20.2 Nanyue Biopharming Corporation Ltd Description, Business Overview
4.20.3 Nanyue Biopharming Corporation Ltd Blood Product Products Offered
4.20.4 Nanyue Biopharming Corporation Ltd Blood Product Revenue and Gross Margin (2017-2022)
4.20.5 Nanyue Biopharming Corporation Ltd Blood Product Revenue by Product in 2021
4.20.6 Nanyue Biopharming Corporation Ltd Blood Product Revenue by Application in 2021
4.20.7 Nanyue Biopharming Corporation Ltd Blood Product Revenue by Geographic Area in 2021
4.20.8 Nanyue Biopharming Corporation Ltd Recent Development
5 Breakdown Data by Type
5.1 Global Blood Product Revenue by Type (2017-2022)
5.2 Global Blood Product Revenue Forecast by Type (2023-2028)
5.3 Blood Product Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Blood Product Revenue by Application (2017-2022)
6.2 Global Blood Product Revenue Forecast by Application (2023-2028)
6.3 Blood Product Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Blood Product Market Size YoY Growth 2017-2028
7.2 North America Blood Product Market Facts & Figures by Country (2017-2028)
7.3 North America Blood Product Revenue by Type (2017-2022)
7.4 North America Blood Product Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Blood Product Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Blood Product Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Blood Product Revenue by Type (2017-2022)
8.4 Asia-Pacific Blood Product Revenue by Application (2017-2022)
9 Europe
9.1 Europe Blood Product Market Size YoY Growth 2017-2028
9.2 Europe Blood Product Market Facts & Figures by Country (2017-2028)
9.3 Europe Blood Product Revenue by Type (2017-2022)
9.4 Europe Blood Product Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Blood Product Market Size YoY Growth 2017-2028
10.2 Latin America Blood Product Market Facts & Figures by Country (2017-2028)
10.3 Latin America Blood Product Revenue by Type (2017-2022)
10.4 Latin America Blood Product Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Blood Product Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Blood Product Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Blood Product Revenue by Type (2017-2022)
11.4 Middle East and Africa Blood Product Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Blood Product Supply Chain Analysis
12.2 Blood Product Key Raw Materials and Upstream Suppliers
12.3 Blood Product Clients Analysis
12.4 Blood Product Sales Channel and Sales Model Analysis
12.4.1 Blood Product Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Blood Product Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Blood Product Distributors
13 Market Dynamics
13.1 Blood Product Industry Trends
13.2 Blood Product Market Drivers
13.3 Blood Product Market Challenges
13.4 Blood Product Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Blood Product Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Companies of Albumin
    Table 3. Major Companies of Immunoglobulin
    Table 4. Major Companies of Clotting Factor
    Table 5. Major Companies of Others
    Table 6. Global Blood Product Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Blood Product Market Size by Region (US$ Million): 2022 VS 2028
    Table 8. Global Blood Product Revenue by Region (2017-2022) & (US$ Million)
    Table 9. Global Blood Product Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 10. Blood Product Revenue by Company (2017-2022) & (US$ Million)
    Table 11. Blood Product Revenue Share by Company (2017-2022)
    Table 12. Ranking of Global Top Blood Product Players by Revenue (US$ Million) in 2021
    Table 13. Global Blood Product Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 14. Global Blood Product by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Product as of 2021)
    Table 15. Global Blood Product Companies Headquarters
    Table 16. Global Blood Product Companies Product & Service
    Table 17. Date of International Companies Enter into Blood Product Market
    Table 18. Global Blood Product Mergers & Acquisitions, Expansion Plans
    Table 19. Takeda Corporation Information
    Table 20. Takeda Description and Business Overview
    Table 21. Takeda Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 22. Takeda Blood Product Product
    Table 23. Takeda Blood Product Revenue Proportion of Blood Product by Product in 2021
    Table 24. Takeda Blood Product Revenue Proportion of Blood Product by Application in 2021
    Table 25. Takeda Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
    Table 26. Takeda Recent Development
    Table 27. CSL Corporation Information
    Table 28. CSL Description and Business Overview
    Table 29. CSL Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 30. CSL Blood Product Product
    Table 31. CSL Blood Product Revenue Proportion of Blood Product by Product in 2021
    Table 32. CSL Blood Product Revenue Proportion of Blood Product by Application in 2021
    Table 33. CSL Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
    Table 34. CSL Recent Development
    Table 35. Grifols Corporation Information
    Table 36. Grifols Description and Business Overview
    Table 37. Grifols Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 38. Grifols Blood Product Product
    Table 39. Grifols Blood Product Revenue Proportion of Blood Product by Product in 2021
    Table 40. Grifols Blood Product Revenue Proportion of Blood Product by Application in 2021
    Table 41. Grifols Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
    Table 42. Grifols Recent Development
    Table 43. Octapharma Corporation Information
    Table 44. Octapharma Description and Business Overview
    Table 45. Octapharma Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 46. Octapharma Blood Product Product
    Table 47. Octapharma Blood Product Revenue Proportion of Blood Product by Product in 2021
    Table 48. Octapharma Blood Product Revenue Proportion of Blood Product by Application in 2021
    Table 49. Octapharma Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
    Table 50. Octapharma Recent Development
    Table 51. Kedrion Corporation Information
    Table 52. Kedrion Description and Business Overview
    Table 53. Kedrion Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 54. Kedrion Blood Product Product
    Table 55. Kedrion Blood Product Revenue Proportion of Blood Product by Product in 2021
    Table 56. Kedrion Blood Product Revenue Proportion of Blood Product by Application in 2021
    Table 57. Kedrion Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
    Table 58. Kedrion Recent Development
    Table 59. LFB Group Corporation Information
    Table 60. LFB Group Description and Business Overview
    Table 61. LFB Group Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 62. LFB Group Blood Product Product
    Table 63. LFB Group Blood Product Revenue Proportion of Blood Product by Product in 2021
    Table 64. LFB Group Blood Product Revenue Proportion of Blood Product by Application in 2021
    Table 65. LFB Group Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
    Table 66. Biotest Corporation Information
    Table 67. Biotest Description and Business Overview
    Table 68. Biotest Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 69. Biotest Blood Product Product
    Table 70. Biotest Blood Product Revenue Proportion of Blood Product by Product in 2021
    Table 71. Biotest Blood Product Revenue Proportion of Blood Product by Application in 2021
    Table 72. Biotest Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
    Table 73. BPL Corporation Information
    Table 74. BPL Description and Business Overview
    Table 75. BPL Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 76. BPL Blood Product Product
    Table 77. BPL Blood Product Revenue Proportion of Blood Product by Product in 2021
    Table 78. BPL Blood Product Revenue Proportion of Blood Product by Application in 2021
    Table 79. BPL Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
    Table 80. Shanghai RAAS Corporation Information
    Table 81. Shanghai RAAS Description and Business Overview
    Table 82. Shanghai RAAS Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 83. Shanghai RAAS Blood Product Product
    Table 84. Shanghai RAAS Blood Product Revenue Proportion of Blood Product by Product in 2021
    Table 85. Shanghai RAAS Blood Product Revenue Proportion of Blood Product by Application in 2021
    Table 86. Shanghai RAAS Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
    Table 87. China Biologic Products Corporation Information
    Table 88. China Biologic Products Description and Business Overview
    Table 89. China Biologic Products Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 90. China Biologic Products Blood Product Product
    Table 91. China Biologic Products Blood Product Revenue Proportion of Blood Product by Product in 2021
    Table 92. China Biologic Products Blood Product Revenue Proportion of Blood Product by Application in 2021
    Table 93. China Biologic Products Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
    Table 94. Hualan Biological Engineering Inc. Corporation Information
    Table 95. Hualan Biological Engineering Inc. Description and Business Overview
    Table 96. Hualan Biological Engineering Inc. Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 97. Hualan Biological Engineering Inc. Blood Product Product
    Table 98. Hualan Biological Engineering Inc. Blood Product Revenue Proportion of Blood Product by Product in 2021
    Table 99. Hualan Biological Engineering Inc. Blood Product Revenue Proportion of Blood Product by Application in 2021
    Table 100. Hualan Biological Engineering Inc. Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
    Table 101. Beijing Tiantan Biological Products Corp Corporation Information
    Table 102. Beijing Tiantan Biological Products Corp Description and Business Overview
    Table 103. Beijing Tiantan Biological Products Corp Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 104. Beijing Tiantan Biological Products Corp Blood Product Product
    Table 105. Beijing Tiantan Biological Products Corp Blood Product Revenue Proportion of Blood Product by Product in 2021
    Table 106. Beijing Tiantan Biological Products Corp Blood Product Revenue Proportion of Blood Product by Application in 2021
    Table 107. Beijing Tiantan Biological Products Corp Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
    Table 108. Pacific Shuanglin Corporation Information
    Table 109. Pacific Shuanglin Description and Business Overview
    Table 110. Pacific Shuanglin Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 111. Pacific Shuanglin Blood Product Product
    Table 112. Pacific Shuanglin Blood Product Revenue Proportion of Blood Product by Product in 2021
    Table 113. Pacific Shuanglin Blood Product Revenue Proportion of Blood Product by Application in 2021
    Table 114. Pacific Shuanglin Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
    Table 115. Boya Bio-Pharmaceutical Corporation Information
    Table 116. Boya Bio-Pharmaceutical Description and Business Overview
    Table 117. Boya Bio-Pharmaceutical Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 118. Boya Bio-Pharmaceutical Blood Product Product
    Table 119. Boya Bio-Pharmaceutical Blood Product Revenue Proportion of Blood Product by Product in 2021
    Table 120. Boya Bio-Pharmaceutical Blood Product Revenue Proportion of Blood Product by Application in 2021
    Table 121. Boya Bio-Pharmaceutical Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
    Table 122. Paisi Feike Biology Pharmacy Co., Ltd. Corporation Information
    Table 123. Paisi Feike Biology Pharmacy Co., Ltd. Description and Business Overview
    Table 124. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 125. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Product
    Table 126. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue Proportion of Blood Product by Product in 2021
    Table 127. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue Proportion of Blood Product by Application in 2021
    Table 128. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
    Table 129. Xinjiang Deyuan Bioengineering Corporation Information
    Table 130. Xinjiang Deyuan Bioengineering Description and Business Overview
    Table 131. Xinjiang Deyuan Bioengineering Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 132. Xinjiang Deyuan Bioengineering Blood Product Product
    Table 133. Xinjiang Deyuan Bioengineering Blood Product Revenue Proportion of Blood Product by Product in 2021
    Table 134. Xinjiang Deyuan Bioengineering Blood Product Revenue Proportion of Blood Product by Application in 2021
    Table 135. Xinjiang Deyuan Bioengineering Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
    Table 136. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Corporation Information
    Table 137. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Description and Business Overview
    Table 138. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 139. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Product
    Table 140. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue Proportion of Blood Product by Product in 2021
    Table 141. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue Proportion of Blood Product by Application in 2021
    Table 142. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
    Table 143. Shenzhen Weiguang Corporation Information
    Table 144. Shenzhen Weiguang Description and Business Overview
    Table 145. Shenzhen Weiguang Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 146. Shenzhen Weiguang Blood Product Product
    Table 147. Shenzhen Weiguang Blood Product Revenue Proportion of Blood Product by Product in 2021
    Table 148. Shenzhen Weiguang Blood Product Revenue Proportion of Blood Product by Application in 2021
    Table 149. Shenzhen Weiguang Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
    Table 150. Shanxi Kangbao Corporation Information
    Table 151. Shanxi Kangbao Description and Business Overview
    Table 152. Shanxi Kangbao Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 153. Shanxi Kangbao Blood Product Product
    Table 154. Shanxi Kangbao Blood Product Revenue Proportion of Blood Product by Product in 2021
    Table 155. Shanxi Kangbao Blood Product Revenue Proportion of Blood Product by Application in 2021
    Table 156. Shanxi Kangbao Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
    Table 157. Nanyue Biopharming Corporation Ltd Corporation Information
    Table 158. Nanyue Biopharming Corporation Ltd Description and Business Overview
    Table 159. Nanyue Biopharming Corporation Ltd Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 160. Nanyue Biopharming Corporation Ltd Blood Product Product
    Table 161. Nanyue Biopharming Corporation Ltd Blood Product Revenue Proportion of Blood Product by Product in 2021
    Table 162. Nanyue Biopharming Corporation Ltd Blood Product Revenue Proportion of Blood Product by Application in 2021
    Table 163. Nanyue Biopharming Corporation Ltd Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
    Table 164. Global Blood Product Revenue by Type (2017-2022) & (US$ Million)
    Table 165. Global Blood Product Revenue by Application (2017-2022) & (US$ Million)
    Table 166. Global Blood Product Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 167. North America Blood Product Revenue by Country (2017-2022) & (US$ Million)
    Table 168. North America Blood Product Revenue by Country (2023-2028) & (US$ Million)
    Table 169. North America Blood Product Revenue by Type (2017-2022) & (US$ Million)
    Table 170. North America Blood Product Revenue by Application (2017-2022) & (US$ Million)
    Table 171. Asia-Pacific Blood Product Revenue by Region (2017-2028) & (US$ Million)
    Table 172. Asia-Pacific Blood Product Revenue by Region (2023-2028) & (US$ Million)
    Table 173. Asia-Pacific Blood Product Revenue by Type (2017-2022) & (US$ Million)
    Table 174. Asia-Pacific Blood Product Revenue by Application (2017-2022) & (US$ Million)
    Table 175. Europe Blood Product Revenue by Country (2017-2022) & (US$ Million)
    Table 176. Europe Blood Product Revenue by Country (2023-2028) & (US$ Million)
    Table 177. Europe Blood Product Revenue by Type (2017-2022) & (US$ Million)
    Table 178. Europe Blood Product Revenue by Application (2017-2022) & (US$ Million)
    Table 179. Latin America Blood Product Revenue by Country (2017-2022) & (US$ Million)
    Table 180. Latin America Blood Product Revenue by Country (2023-2028) & (US$ Million)
    Table 181. Latin America Blood Product Revenue by Type (2017-2022) & (US$ Million)
    Table 182. Latin America Blood Product Revenue by Application (2017-2022) & (US$ Million)
    Table 183. Middle East and Africa Blood Product Revenue by Country (2017-2022) & (US$ Million)
    Table 184. Middle East and Africa Blood Product Revenue by Country (2023-2028) & (US$ Million)
    Table 185. Middle East and Africa Blood Product Revenue by Type (2017-2022) & (US$ Million)
    Table 186. Middle East and Africa Blood Product Revenue by Application (2017-2022) & (US$ Million)
    Table 187. Blood Product Key Raw Materials, Industry Status and Trend
    Table 188. Blood Product Key Raw Materials and Upstream Suppliers
    Table 189. Blood Product Clients Status and Trend
    Table 190. Blood Product Typical Clients
    Table 191. Blood Product Distributors
    Table 192. Blood Product Market Trends
    Table 193. Blood Product Market Drivers
    Table 194. Blood Product Market Challenges
    Table 195. Blood Product Market Restraints
    Table 196. Research Programs/Design for This Report
    Table 197. Key Data Information from Secondary Sources
    Table 198. Key Data Information from Primary Sources
List of Figures
    Figure 1. Blood Product Product Picture
    Figure 2. Global Blood Product Revenue Market Share by Type in 2021 & 2028
    Figure 3. Albumin Product Picture
    Figure 4. Immunoglobulin Product Picture
    Figure 5. Clotting Factor Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Blood Product Revenue Market Share by Application in 2021 & 2028
    Figure 8. Bleeding Wound
    Figure 9. Immunodeficiency
    Figure 10. HBV
    Figure 11. Tetanus
    Figure 12. Rabies
    Figure 13. Hemophilia
    Figure 14. Others
    Figure 15. Blood Product Report Years Considered
    Figure 16. Global Blood Product Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Blood Product Market Size 2017-2028 (US$ Million)
    Figure 18. Global Blood Product Market Size Market Share by Region: 2022 Versus 2028
    Figure 19. Global Blood Product Revenue Market Share by Region (2017-2028)
    Figure 20. Blood Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 21. Global Blood Product Revenue Market Share Forecast by Type (2017-2028)
    Figure 22. Global Blood Product Revenue Market Share Forecast by Application (2017-2028)
    Figure 23. North America Blood Product Revenue 2017-2028 (US$ Million)
    Figure 24. North America Blood Product Revenue Market Share by Type (2017-2022)
    Figure 25. North America Blood Product Revenue Market Share by Application (2017-2022)
    Figure 26. Asia-Pacific Blood Product Revenue 2017-2028 (US$ Million)
    Figure 27. Asia-Pacific Blood Product Revenue Market Share by Region (2017-2028)
    Figure 28. Asia-Pacific Blood Product Revenue Market Share by Type (2017-2022)
    Figure 29. Asia-Pacific Blood Product Revenue Market Share by Application (2017-2022)
    Figure 30. Europe Blood Product Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 31. Europe Blood Product Revenue Market Share by Country (2017-2028)
    Figure 32. Europe Blood Product Revenue Market Share by Type (2017-2022)
    Figure 33. Europe Blood Product Revenue Market Share by Application (2017-2022)
    Figure 34. Latin America Blood Product Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 35. Latin America Blood Product Revenue Market Share by Country (2017-2022)
    Figure 36. Latin America Blood Product Revenue Market Share by Type (2017-2022)
    Figure 37. Latin America Blood Product Revenue Market Share by Application (2017-2022)
    Figure 38. Middle East and Africa Blood Product Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 39. Middle East and Africa Blood Product Revenue Market Share by Country (2017-2028)
    Figure 40. Middle East and Africa Blood Product Revenue Market Share by Type (2017-2022)
    Figure 41. Middle East and Africa Blood Product Revenue Market Share by Application (2017-2022)
    Figure 42. Blood Product Supply Chain (Upstream and Downstream Market)
    Figure 43. Global Production Market Share of Blood Product Raw Materials by Region in 2021
    Figure 44. Blood Product Distribution Channels
    Figure 45. Global Blood Product Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 46. Global Blood Product Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 47. Bottom-up and Top-down Approaches for This Report
    Figure 48. Data Triangulation
    Figure 49. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Teledentistry Market Insights Forecast to 2028
Global Teledentistry Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-2H10407
Mon Oct 24 00:00:00 UTC 2022

Add to Cart

Global Digital Biomarker Market Insights and Forecast to 2028
Global Digital Biomarker Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-6Y6173
Mon Oct 24 00:00:00 UTC 2022

Add to Cart

Global Cord Blood Bank Market Insights and Forecast to 2028
Global Cord Blood Bank Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-1W8941
Sun Oct 23 00:00:00 UTC 2022

Add to Cart

Global Animal Cell Culture Market Insights and Forecast to 2028
Global Animal Cell Culture Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-25E8478
Sun Oct 23 00:00:00 UTC 2022

Add to Cart